Horizon Scanning overviews

In Horizon Scanning, we prepare overviews of new medicinal products, indication extensions, and line extensions currently under evaluation by the EMA. The purpose of these overviews is to provide a consolidated view of the authorisation process. They show how far individual applications and marketing authorisations have progressed and make it easier to follow developments in the field. The overviews visualise the process and create transparency around how new medicinal products progress through the EMA’s evaluation.

The documents below are the latest published.

You are always welcome to write to us at horizonscanning@amgros.dk, if you have any questions regarding a overview.

Sorting

New medicines Extensions of indication Other extensions Show all